Bharat Biotech chalks out capex planIllustrative image – not actual.

Bharat Biotech International is mulling to invest Rs 325 crore in clinical research and setting up a manufacturing facility.

Of the total, Rs 250 crore is likely to be pumped in clinical research activities and Rs 75 crore in setting up a new facility at the company's existing campus in Hyderabad.

The capex plan is to funded internal accruals, grants from the Department of Biotechnology and international agencies.

← All latest storiesBack to top →